Benzinga | Aug 4, 2021 07:12AM EDT

Ionis Pharmaceuticals Q2 EPS $(0.57) Beats $(0.58) Estimate, Sales $126.00M Miss $129.94M Estimate

Ionis Pharmaceuticals (NASDAQ:IONS) reported quarterly losses of $(0.57) per share which beat the analyst consensus estimate of $(0.58) by 1.72 percent. This is a 147.83 percent decrease over losses of $(0.23) per share from the same period last year. The company reported quarterly sales of $126.00 million which missed the analyst consensus estimate of $129.94 million by 3.03 percent. This is a 13.70 percent decrease over sales of $146.00 million the same period last year.